WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006090261) BICYCLIC HETEROAROMATIC DERIVATIVES USEFUL AS ANTICANCER AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/090261    International Application No.:    PCT/IB2006/000406
Publication Date: 31.08.2006 International Filing Date: 15.02.2006
Chapter 2 Demand Filed:    03.03.2006    
IPC:
C07D 519/00 (2006.01), A61K 31/519 (2006.01), A61K 31/438 (2006.01), A61P 35/00 (2006.01)
Applicants: PFIZER PRODUCTS INC. [US/US]; Eastern Point Road, Groton, CT 06340 (US) (For All Designated States Except US).
KAUFFMAN, Goss, Stryker [US/US]; (US) (For US Only).
LI, Chao [US/US]; (US) (For US Only).
LIPPA, Blaise, Scott [US/US]; (US) (For US Only).
MORRIS, Joel [US/US]; (US) (For US Only).
PAN, Gonghua [CN/US]; (US) (For US Only)
Inventors: KAUFFMAN, Goss, Stryker; (US).
LI, Chao; (US).
LIPPA, Blaise, Scott; (US).
MORRIS, Joel; (US).
PAN, Gonghua; (US)
Agent: FULLER, Grover, J., Jr.; c/o DROUIN, Stéphane, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ (GB)
Priority Data:
60/656,467 24.02.2005 US
Title (EN) BICYCLIC HETEROAROMATIC DERIVATIVES USEFUL AS ANTICANCER AGENTS
(FR) DERIVES HETEROAROMATIQUES BICYCLIQUES UTILISES COMME AGENTS ANTICANCEREUX
Abstract: front page image
(EN)The invention relates to compounds of the formula I: and to pharmaceutically acceptable salts and solvates thereof, wherein X, Z, V, W, R4, R5, R6, R7, and ring B are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula I and to pharmaceutical compositions for treating such disorders which contain the compounds of formula I. The invention also relates to methods of preparing the compounds of formula I.
(FR)La présente invention concerne des composés représentés par la formule (I) ainsi que des sels et solvates pharmaceutiquement acceptables de ceux-ci. Dans cette formule, X, Z, V, W, R4, R5, R6, R7 et le cycle B sont tels que définis dans la description. Cette invention porte également sur des méthodes de traitement d'une croissance cellulaire anormale chez des mammifères consistant à administrer les composés représentés par la formule (I), ainsi que sur des compositions pharmaceutiques servant au traitement de tels troubles et contenant les composés représentés par la formule (I). Cette invention concerne enfin des procédés de préparation des composés représentés par la formule (I).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)